NOVAVAX INC Prepaid Supplies
NOVAVAX INC (NVAX) had Prepaid Supplies of $16.95 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:Supplies · last filed 2026-02-26
- 2025-12-31: Prepaid Supplies $16.95M.
- 2024-12-31: Prepaid Supplies $56.28M.
- 2023-12-31: Prepaid Supplies $70.30M.
- 2022-12-31: Prepaid Supplies $160.77M.
| Period end | Prepaid Supplies | Prepaid Supplies as first filed |
|---|---|---|
| 2025-12-31 | $16.95M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $56.28M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $70.30M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $160.77M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $120.03M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $171.60M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $3.60M 10-K · filed 2021-03-01 | $4.38M 10-K · filed 2020-03-11 |
| 2018-12-31 | $11.97M 10-K · filed 2020-03-11 | |
| 2017-12-31 | $13.09M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $15.74M 10-K · filed 2018-03-14 | |
| 2015-12-31 | $12.97M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $7.56M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $1.75M 10-K · filed 2015-02-27 | |
| 2012-12-31 | $1.59M 10-K · filed 2014-03-12 | |
| 2011-12-31 | $1.62M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |